1270 related articles for article (PubMed ID: 2828913)
21. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
Wurch T; Palmier C; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
De Vivo M; Maayani S
J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
[TBL] [Abstract][Full Text] [Related]
23. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
[TBL] [Abstract][Full Text] [Related]
24. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Schoeffter P; Hoyer D
Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
[TBL] [Abstract][Full Text] [Related]
25. Agonist- and antagonist-induced plasticity of rat 5-HT1A receptor in hippocampal cell culture.
Nishi M; Azmitia EC
Synapse; 1999 Mar; 31(3):186-95. PubMed ID: 10029236
[TBL] [Abstract][Full Text] [Related]
26. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
Bouhelal R; Smounya L; Bockaert J
Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
[TBL] [Abstract][Full Text] [Related]
27. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
28. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
[TBL] [Abstract][Full Text] [Related]
29. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189
[TBL] [Abstract][Full Text] [Related]
30. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
Schoeffter P; Hoyer D
J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
[TBL] [Abstract][Full Text] [Related]
31. Modulation of voltage-dependent calcium currents by serotonin in acutely isolated rat amygdala neurons.
Lin CH; Huang YC; Tsai JJ; Gean PW
Synapse; 2001 Sep; 41(4):351-9. PubMed ID: 11494406
[TBL] [Abstract][Full Text] [Related]
32. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
33. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission.
Costa L; Trovato C; Musumeci SA; Catania MV; Ciranna L
Hippocampus; 2012 Apr; 22(4):790-801. PubMed ID: 21538661
[TBL] [Abstract][Full Text] [Related]
34. Characterization of serotonin-1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from the opossum.
Murphy TJ; Bylund DB
J Pharmacol Exp Ther; 1989 May; 249(2):535-43. PubMed ID: 2542534
[TBL] [Abstract][Full Text] [Related]
35. Serotonin 5-HT1 receptors mediate inhibition of cyclic AMP production in neurons.
Weiss S; Sebben M; Kemp DE; Bockaert J
Eur J Pharmacol; 1986 Jan; 120(2):227-30. PubMed ID: 3005002
[TBL] [Abstract][Full Text] [Related]
36. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
37. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat.
Mørk A; Geisler A
Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981
[TBL] [Abstract][Full Text] [Related]
38. Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.
Deliganis AV; Pierce PA; Peroutka SJ
Biochem Pharmacol; 1991 Jun; 41(11):1739-44. PubMed ID: 1828347
[TBL] [Abstract][Full Text] [Related]
39. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
Adrien J; Lanfumey L; Gozlan H; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1989 Mar; 248(3):1222-30. PubMed ID: 2522986
[TBL] [Abstract][Full Text] [Related]
40. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
